-

San Diego Academy of Regenerative Therapies (SDARTs) Announces 4th Annual Conference Featuring World’s Leading Experts in Microfat, Nanofat, PRP and Energy Devices

3-Day Symposium Explores Rapid Advances in the World of Regenerative Therapies, hosted at University of California San Diego’s School of Medicine

SAN DIEGO--(BUSINESS WIRE)--For the 4th year in a row, SDARTs will present clinical and scientific education in the latest advances in regenerative therapies, with a focus on using adipose (fat) tissue as an abundant source of regenerative cells. A well-respected faculty from around the world will converge at UCSD for hands-on cadaver practicum and in-depth didactic sessions covering both aesthetic and functional procedures.

“Last year’s conference was a tremendous success,” reports Marcille Pilkington, CEO of SDARTs. “We had nearly 150 attendees and faculty from 19 countries, representing experts and practitioners of leading-edge regenerative therapies. This year, we’ll build on that success with a focus on the latest applications in this fast-growing new field. We believe that regenerative medicine, or using a patient’s own tissue to rejuvenate and repair their own body, will change the way we care for patients.”

Keynote presentations will feature the original pioneers of nanofat, plastic surgeons Patrick Tonnard, MD, PhD and Alexis Verpaele, MD, PhD from Belgium. (https://www.tonnardverpaele.com/)

Other speakers include:

Robert Alexander, MD, DMD, FICS; internationally recognized aesthetic & reconstructive surgeon, author, teacher, pioneer in use of stem/stromal cells in clinical practice, and a recognized leader in the field of Biocellular Regenerative Medicine.

J. Peter Rubin, MD; UPMC Endowed Professor and Chair of Plastic Surgery, Director, Adipocyte Biology Laboratory University of Pittsburgh, Co-director UPMC Aesthetic Plastic Surgery Center

Ramon Llull, MD, PhD, (https://plasticamallorca.com/en/dr-ramon-llull/); Founder Cell Pro Tech Spain SLU, a Cell Therapy Translational and Clinical Research Center; Medical Director of Plastica Mallorca Plastic Surgery Clinic; first to publish scientific characterization of the biology of nanofat.

Full faculty list: https://sdarts.com/annual-conference/faculty

“It makes sense to utilize safe, accessible, abundant adipose tissue as a source of cells that will enable the regenerative strategies of the future,’ said Ramon Llull, PhD.

View Interview from 2019 Conference

Conference Registration: https://sdarts.com/register

SDARTs offers training courses in surgical and minimally invasive office-based procedures using regenerative therapies in Aesthetic Medicine, Plastic and Reconstructive Surgery, and Regenerative Medicine. The faculty instructs using clinically proven protocols that ensure reproducibility in the office-based practice.

Contacts

Malaysia Sukcharoun
Marketing/Event Coordinator
619-804-2089
info@sdarts.com

San Diego Academy of Regenerative Therapies


Release Versions

Contacts

Malaysia Sukcharoun
Marketing/Event Coordinator
619-804-2089
info@sdarts.com

More News From San Diego Academy of Regenerative Therapies

San Diego Academy of Regenerative Therapies (SDARTs) 4th Global Conference Spotlights Regenerative Stem Cell Treatments for Hair Restoration

SAN DIEGO--(BUSINESS WIRE)--The 4th global SDARTs conference features a highly respected, international faculty presenting the latest advances in treatments that use the body’s own tissue to repair and rejuvenate patients. "This year's conference will be unique for several reasons," reports Marcille Pilkington, CEO of SDARTs. "Obviously, having a hybrid conference lets us reach a broader group of health care providers. We’ve also added new presenters who have developed exciting new regenerative...

San Diego Academy of Regenerative Therapies (SDARTs) 4th Global Conference Features Update on Clinical Trial Treating Post-COVID Patients Using Cells From Fat Tissue

SAN DIEGO--(BUSINESS WIRE)--The 4th global SDARTs conference features a highly respected faculty in the latest scientific data and techniques for using adipose (fat) tissue as an abundant source of regenerative cells. "At the Conference, Dr. Robert Alexander will report on his ongoing FDA-approved clinical trial using adipose-derived cells to treat post-COVID-19 lung damage. This panel will be the highlight of this Conference," reports Marcille Pilkington, CEO of SDARTs. "In addition, Dr. Ramon...

Now Recruiting Patients for a New FDA Oversight Trial Evaluating the Use of a Patient's Own Fat Tissue for the Treatment of Post-COVID-19 Lung Damage

SAN DIEGO--(BUSINESS WIRE)--Tulip Medical (a dba of Black Tie Medical, Inc.) has sponsored and funded a new FDA Oversight Trial that seeks to restore respiratory function in adults who have suffered lung damage from the COVID-19 virus. Robert W. Alexander, MD, DMD, FICS is the Principal Investigator, and his office is recruiting patients for enrollment in the trial. "We're building on two years of existing trials in patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and Farmer...
Back to Newsroom